<DOC>
	<DOC>NCT01941914</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect of calcium electroporation on keloids.</brief_summary>
	<brief_title>Calcium Electroporation for the Treatment of Keloids</brief_title>
	<detailed_description>The keloids wil be treated with intratumoral injection of calcium followed by electroporation. It is a once only treatment and the patients will be followed up for 24 months.</detailed_description>
	<mesh_term>Keloid</mesh_term>
	<mesh_term>Calcium, Dietary</mesh_term>
	<criteria>At least 1 keloid available to electroporation. Patient should have been offered standard treatment. At least 8 weeks since other keloid treatment. Performance status &lt;2 (ECOG). Platelet count &gt;50 mia/l International Normalized Ratio (INR) &lt;1,2. Age &gt;18. Patient should be able to understand participants information. Signed, informed consent. Clinically significant coagulopathy. Pregnancy or lactation. Participation in other clinical trial involving experimental drugs or participation in a clinical trial within 4 weeks before study treatment.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Calcium electroporation</keyword>
	<keyword>calcium</keyword>
	<keyword>electroporation</keyword>
	<keyword>electrotransfer</keyword>
	<keyword>keloid</keyword>
</DOC>